Environmental and chemical carcinogenesis

Seminars in Cancer Biology

Volumn 14, Issue 6, 2004, Pages 473-486

  Wogan, Gerald N ^a   Hecht, Stephen S ^b   Felton, James S ^c   Conney, Allan H ^d   Loeb, Lawrence A ^e  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aflatoxin; Carcinogen metabolism; Colon cancer; Genetic polymorphism; Hepatitis viruses; Heterocyclic amines; Liver cancer; Lung cancer; Mutator phenotype; Tobacco carcinogens

Indexed keywords

AFLATOXIN; BIOLOGICAL MARKER; CARCINOGEN; CYTOCHROME P450; DNA; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HETEROCYCLIC AMINE; N (2 FLUORENYL)ACETAMIDE;

AFRICA; ASIA; BREAST CANCER; CANCER CELL; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; COLON CANCER; DIET; DNA ADDUCT; DNA DAMAGE; DNA SEQUENCE; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FOOD; GENE MUTATION; GENETIC POLYMORPHISM; HEPATITIS B VIRUS; HEREDITY; HUMAN; LIFESTYLE; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MEAT; MOLECULAR BIOLOGY; NONHUMAN; ONCOGENE; PHENOTYPE; REVIEW; RISK FACTOR; SMOKING; STOMACH CANCER; SUPPRESSOR GENE; TOBACCO; TUMOR GROWTH; VALIDATION PROCESS; VIRUS INFECTION;

EID: 5444239783     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2004.06.010     Document Type: Article

References (61)

1. Hepatitis viruses, vol. 59. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, France; 1994.
2. Kew M.C. Hepatitis viruses and hepatocellular carcinoma. Res Virol. 149:1998;257-262
3. Wogan G.N. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52:1992;2114s-2118s
4. Bosch F.X., Munoz N. Prospects for epidemiological studies on hepatocellular carcinoma as a model for assessing viral-chemical interactions. IARC Scientific Pub. 89:1988;427-433
5. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins, vol. 53. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, France; 1993.
6. Wogan G.N. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research. Environ Health Persp. 98:1992;167-178
7. Groopman J.D., Kensler T.W. The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis. 20:1999;1-11
8. Ross R.K., Yuan J.-M., Yu M.C., Wogan G.N., Qian G.-S., Tu J.-T., et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 339:1992;943-946
9. Qian G.-S., Ross R.K., Yu M.C., Yuan J.-M., Gao Y.-T., Henderson B.E., et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epi Biomark Prev. 3:1994;3-10
10. Wang L.-Y., Hatch M., Chen C.J., Levin B., You S.L., Lu S.N., et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer. 67:1996;620-625
11. Sun Z., Lu P., Gail M.H., Pee D., Zhang Q., Ming L., et al. Increased risk of hepatocellular carcinoma in male HBsAg carriers with chronic hepatitis who have detectable aflatoxin metabolite M1. Hepatology. 2:1999;379-383
12. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878
13. 1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst. 91:1999;347-354
14. Tobacco smoke and involuntary smoking, vol. 83. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, France; 2004.
15. Tobacco habits other than smoking: betel quid and area nut chewing and some related nitrosamines, vol. 37. International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Lyon, France; 1985. p. 37-202.
16. Hecht S.S. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nature Rev Cancer. 3:2003;733-744
17. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 91:1999;1194-1210
18. Hecht S.S., Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9:1988;875-884
19. Polynuclear aromatic compounds. Part 1, chemical, environmental, and experimental data, vol. 32. International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Lyon, France; 1983. p. 33-91.
20. Hoffmann D, Schmeltz I, Hecht SS, Wynder EL. Tobacco carcinogenesis. In: Gelboin H, Ts'o POP, editors. Polycyclic hydrocarbons and cancer. New York: Academic Press; 1978. p. 85-117.
21. Deutsch-Wenzel R., Brune H., Grimmer G. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J Natl Cancer Inst. 71:1983;539-544
22. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 11:1998;559-603
23. Hecht S.S. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis. 23:2002;907-922
24. Weisburger J.H., Grantham P.H., Vanhorn E.C., Steigbigel N.H., Rall D.P., Weisburger E.K. Activation and detoxification of N-2-fluorenylacetamide in man. Cancer Res. 24:1964;475-479
25. Conney AH, Pantuck EJ, Pantuck CB, Buening MK, Jerina DM, Fortner JG, et al. Role of environment and diet in the regulation of human drug metabolism. In: Estabrook RW, Lindenlaub E, editors. The induction of drug metabolism. New York: FKSchattauer Verlag; 1979. p. 583-605.
26. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: GHA Clowes Memorial Lecture. Cancer Res. 42:1982;4875-4917
27. Ingelman-Sundberg M. Implications of polymorphic cytochrome P450-dependent drug metabolism for drug development. Drug Metab Dispos. 29:2001;570-573
28. Conney A.H. Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450. Annu Rev Pharmacol Toxicol. 43:2003;1-30
29. Richardson H.L., Stier A.R., Borsos-Nacht-Nebel E. Liver tumor inhibition and adrenal histologic responses in rats to which 3′-methyl-4- dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered. Cancer Res. 12:1952;356-361
30. Conney A.H., Miller E.C., Miller J.A. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res. 16:1956;450-459
31. Miller E.C., Miller J.A., Brown R.R., MacDonald J.C. On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. Cancer Res. 18:1958;469-477
32. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 46:1978;279-303
33. Poland A., Palen D., Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature. 300:1982;271-273
34. DiGiovanni J, Berry DL, Slaga TJ, Juchau MR. Studies on the relationships between induction of biotransformation and tumor-initiating activity of 7,12-dimethylbenz[a]anthracene in mouse skin. In: Jones PW, Leber P, editors. Polynuclear aromatic hydrocarbons. Ann Arbor, MI: Ann Arbor Science Publishers; 1979. p. 553-68.
35. DiGiovanni J, Kishore GS, Slaga TJ, Boutwell RK. 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD)-induced alterations in oxidative and nonoxidative biotransformation of PAH in mouse skin: role of anticarcinogenesis by TCDD. In: Bjorseth O, Dennis AJ, editors. Polynuclear aromatic hydrocarbons: chemistry and biological effects. Columbus, OH: Battalle Press; 1980. p. 935-54.
36. Verma A.K., Shapas B.G., Rice H.M., Boutwell R.K. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res. 39:1979;419-425
37. 3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. Biochem Biophys Res Commun. 116:1983;605-611
38. 3 on the formation of skin tumors in mice treated chronically with 7,12-dimethylbenz[a]anthracene.. Biochem Biophys Res Commun. 130:1985;924-931
39. Verma A.K., Conrad E.A., Boutwell R.K. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res. 42:1982;3519-3525
40. Conney A.H., Lou Y.-R., Xie J.-G., Osawa T., Newmark H.L., Liu Y., et al. Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med. 216:1997;234-245
41. Omenn G.S. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health. 19:1998;73-99
42. Baron J.A., Cole B.F., Mott L., Haile R., Grau M., Church T.R., et al. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst. 95:2003;717-722
43. Loeb L.A. Endogenous carcinogenesis: molecular oncology into the twenty-first century - presidential address. Cancer Res. 49:1989;5489-5496
44. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 362:1993;709-715
45. Ames B.N., Gold L.S., Willet W.C. The causes and prevention of cancer. Proc Natl Acad Sci USA. 92:1995;5258-5265
46. Wood R.D., Mitchell M., Sgouros J., Lindahl T. Human DNA repair genes. Science. 29:2001;1284-1289
47. Loeb L.A. A mutator phenotype in cancer. Cancer Res. 61:2001;3230-3239
48. Cervantes R.B., Stringer J.R., Shao C., Tischfield J.A., Stambrook P.J. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA. 99:2002;3586-3590
49. Loeb L.A., Springgate C.F., Battula N. Errors in DNA replication as a basis of malignant change. Cancer Res. 34:1974;2311-2321
50. Knudson A.G. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol. 122:1996;135-140
51. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
52. Vogelstein B., Fearon E.R., Kern S.E., Hamilton S.R., Preisinger A.C., Leppert M., et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 319:1988;525-532
53. Kallioniemi A., Kallioniemi O.-P., Piper J., Tanner J.M., Stokke T., Chen L., et al. Detecton and mapping of amplified DNA sequences in breast cancer by comparative gnomic hybridization. Proc Natl Acad Sci USA. 91:1994;2156-2160
54. Klein C.A., Schmidt-Kittler O., Schardt J.A., Pantel K., Speicher M.R., Riethmuller G. Comparative gnomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA. 96:1999;4494-4499
55. Perucho M. Cancer of the microsatellite mutator phenotype. Biol Chem. 377:1996;675-684
56. Jackson A.L., Loeb L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res. 477:2001;187-198
57. Cleaver JE, Kraemer KH. Xeroderma pigmentosum. In: Scriver CR, Beudet AL, Sly WS, Valle D, editors. The metabolic bases of inherited disease. New York: McGraw-Hill; 1989. p. 2949-71.
58. Goldsby R.E., Hays L.E., Chen X., Olmsted E.A., Slayton W.B., Spangrude G.J., et al. High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading. Proc Natl Acad Sci USA. 99:2002;15560-15565
59. Duesberg P., Rausch C., Rasnick D., Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci USA. 95:1998;13692-13697
60. Tomlinson I., Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Med. 5:1999;11-12
61. Wang T.L., Rago C., Silliman N., Ptak J., Markowitz S., Wilson J.K., et al. Prevalance of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci USA. 99:2002;3076-3080